Improving Women's Cardiovascular Health: A Position Statement From the International Council on Women's Health Issues

Davidson, Patricia M.; Meleis, Afaf Ibrahim; McGrath, Sarah J.; DiGiacomo, Michelle; Dharmendra, Tessa; Puzantian, Houry; Song, MinKyoung; Riegel, Bárbara

doi:10.1080/07399332.2011.646375

Cited by 6 publications

(2 citation statements)

References 38 publications

(25 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In these, the necessity of recognizing and addressing the needs of women with regard to chronic diseases with focus oriented toward CVDs was underscored for researchers, health practitioners, and policy-makers. 72,73…”

Section: Female-centered Policies and Practices In Global Cvdmentioning

confidence: 99%

<p>Cardiovascular Diseases in Women: Policies and Practices Around the Globe to Achieve Gender Equity in Cardiac Health</p>

Kouvari¹,

Souliotis²,

Yannakoulia³

et al. 2020

RMHP

View full text Add to dashboard Cite

The women's global health agenda has recently been reformulated to address more accurately cardiovascular disease (CVD) prevention, diagnosis, and treatment. The aim of the present work was to review the global and national policies and practices that address sex equality in health with a focus on CVDs in women. Scientific databases and health organizations' websites that presented/discussed policies and initiative targeting to enhance a sex-centered approach regarding general health and/or specifically cardiac health care were reviewed in a systematic way. In total, 61 relevant documents were selected. The selected policies and initiatives included position statements, national action plans, evidence-based guidelines, guidance/recommendations, awareness campaigns, regulations/legislation, and state-of-the art reports by national/international projects and conferences. The target audiences of large stakeholders (eg, American Heart Association, European Society of Cardiology, Centers for Disease Control and Prevention) were female citizens, health professionals, and researchers. Much as policy-makers have recognized the sex/gender gap in the CVD field, there is still much to be done. Thereby, tailor-made strategies should be designed, evaluated, and delivered on a global and most importantly a national basis to achieve gender equity with regard to CVDs.

show abstract

Section: Female-centered Policies and Practices In Global Cvdmentioning

confidence: 99%

<p>Cardiovascular Diseases in Women: Policies and Practices Around the Globe to Achieve Gender Equity in Cardiac Health</p>

Kouvari¹,

Souliotis²,

Yannakoulia³

et al. 2020

RMHP

View full text Add to dashboard Cite

show abstract

“…Considering the fact that it is absolutely necessary to promote both primary and secondary prevention of cardiovascular disease , it has become important to formulate guidelines specific for women. The main guidelines by different international institutions are shown in Table .…”

Section: Treatment Of Coronary Risk Factors In Womenmentioning

confidence: 99%

Prevention and Treatment of Cardiovascular Disease in Women: The Obstetric‐Gynecologist's Point of View

Perrone

Brunelli

2013

Ther Apher Dial

View full text Add to dashboard Cite

It has been confirmed that cardiovascular disease (CVD) is the leading cause of morbidity and mortality not only in men but also in women. The most recent American Heart Association (AHA) and European Atherosclerosis Society (EAS) recommendations specifically address women. This is in response to the majority of studies that primarily involved men. Ideal cardiovascular health has been defined for women, and new factors were added to the traditional risk factors. As stated by the American and European Menopause Societies (NAMS and EMAS), hormone replacement therapy (HRT) is no longer believed to be protective for CVD; on the contrary, women benefit just as much as men from statins to lower their risk of heart disease. At the onset of menopause, women exhibit an increase in cholesterol and an increased risk of CVD. Unfortunately, hyperlipidemia is largely undertreated in women, although the rate of hypercholesterolemia among women is similar to that of men. More aggressive intervention is recommended for persons with multiple risk factors and/or monogenic dyslipidemias. In women affected by familial hypercholesterolemia in the homozygous and compound forms, treatment such as lipoprotein apheresis is also suggested. There is evidence for the use of these techniques even in pregnancy. An update on the most recent guidelines issued by AHA, EAS, NAMS and EMAS for the prevention of CVD in women along with a brief overview on the use of lipoprotein apheresis in women during pregnancy is reported.

show abstract

Clinical Interventions to Empower Older Women

O’Brien

Whitbourne

2014

Women and Aging

View full text Add to dashboard Cite

Improving Women's Cardiovascular Health: A Position Statement From the International Council on Women's Health Issues

Cited by 6 publications

References 38 publications

<p>Cardiovascular Diseases in Women: Policies and Practices Around the Globe to Achieve Gender Equity in Cardiac Health</p>

<p>Cardiovascular Diseases in Women: Policies and Practices Around the Globe to Achieve Gender Equity in Cardiac Health</p>

Prevention and Treatment of Cardiovascular Disease in Women: The Obstetric‐Gynecologist's Point of View

Clinical Interventions to Empower Older Women

Contact Info

Product

Resources

About